Baxter International (BAX) Q2 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 30, 2026.
Q2 2026
EPS
$0.56
est $0.37
+52.5%
Revenue
$2.96B
est $2.80B
+5.9%
Baxter International beat Q2 EPS by 52% and lifted full-year guidance after all segments posted organic growth, with a $0.11-per-share tariff refund sealing the beat. Advanced Surgery drove particularly strong momentum with 12% organic growth, though gross margins compressed 210 basis points year-over-year as higher-cost inventory from late 2025 rolled through cost of sales.